ホーム>>Signaling Pathways>> Microbiology & Virology>> Antibiotic>>Avermectin B1b

Avermectin B1b (Synonyms: Abamectin B1b, Antibiotic C 076B1b)

カタログ番号GC15966

昆虫殺虫剤と寄生虫駆除薬

Products are for research use only. Not for human use. We do not sell to patients.

Avermectin B1b 化学構造

Cas No.: 65195-56-4

サイズ 価格 在庫数 個数
500ug
$376.00
在庫あり
2.5mg
$1,408.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Avermectins are insecticides and anthelmintics first isolated from broths fermented by S. avermitilis.[1] They potentiate glutamate- and GABA-gated chloride channel opening in nematodes.[2],[3] Avermectin B1b is a minor component of avermectin broth.[2] Avermectins, including avermectin B1b, are used broadly against nematodes, ticks, flies, and ants.[2]

Reference:
[1]. Egerton, J.R., Ostlind, D.A., Blair, L.S., et al. Avermectins, new family of potent anthelmintic agents: Efficacy of the B1a component. Antimicrobial Agents and Chemotherapy 15(3), 372-378 (1979).
[2]. Duke, S.O., Cantrell, C.L., Meepagala, K.M., et al. Natural toxins for use in pest management. Toxins (Basel) 2(8), 1943-1962 (2010).
[3]. Arena, J.P., Liu, K.K., Paress, P.S., et al. The mechanism of action of avermectins in Caenorhabditis elegans: Correlation between activation of glutamate-sensitive chloride current, membrane binding, and biological activity. Journal of Parasitology 81(2), 286-294 (1995).

レビュー

Review for Avermectin B1b

Average Rating: 5 ★★★★★ (Based on Reviews and 30 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Avermectin B1b

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.